What's going on, Nymphenfem? Welcome back to another video. If you guys are new to the channel, make sure you guys hit that subscribe button, turn on your post notification bell, leave a positive comment down below for a chance to get a what? For a chance to get a shout out in the next video. That is right, guys. So we're in the car right now. We're currently at the vet. Kind of like a weird start to the day. First vlog being back from Jamaica. Not so much the best one, but this is something that we had planned already, as you guys know, if you guys watched our previous videos. Today is Blooper's surgery. So today he is going to be getting four cysts removed, along with him getting neutered. They told us to drop him off between the hours of eight and nine in the morning, which right now it's 8.43. And they said that we'd be able to pick him up around four in the afternoon. As you guys can see, he's pretty calm right now. He's a little shaky. I don't know if it's because he's cold or he's like a little nervous because he knows where he's at. But, Nene, you okay? You okay?  I know. Oh, okay, okay, okay. I don't know what that means. I don't know what that means, but okay. Oh, my baby.  Okay?  You gonna give me a hug? Give daddy a kiss. Give me a kiss, give me a kiss. Give daddy a kiss. Give me a kiss, come on. He carried you. Oh, thank you, thank you, thank you, thank you, Nene.   Mama had to be strong because mama, mama cries for everything. Right, you handled that really well. I'm really surprised you didn't cry. Give me some, I'm really proud of that. I just felt like if I did cry, like he would feel it and I didn't want him to be worried, so mama had to be strong. Guys, he's like in the best reviewed vent around like our area, like five star vent kind of thing. I did a lot of research before choosing this place, so and also like the people in there, you saw like how caring they were when they took him over and all that. Like I feel like he's in really good hands. Yeah, I also feel like he's in good hands. Like the girl who took him was very loving and I feel like I feel more comfortable with handing my dog to someone if they're dog people and they like dogs. So it's not just her dog, you can tell that she really liked him and that just gave me some comfort right there. Right, and we also asked that after the surgery if the doctor could please give us a call just for like peace of mind to let us know how the surgery went and all that. They said they just do that by default. That's something that they just routinely do. So I was like, okay, great, perfect.  But in the meantime, we're actually trying to find a diner right now. I remember seeing one, I just don't remember where I'm trying to figure it out, but we're gonna grab some food. Afterwards, we're gonna hit up like Petco or PetSmart, whichever one it is that it's called, I forget. We're gonna try to get bloopers, some good old treats. And what else do you think? He needs a new tag. He needs a new tag.  So we need a good one and that's pretty much it. So we'll see you there. Found a diner. It was exactly where I thought it was. I'm a human GPS, right babe? Sometimes. Sometimes, okay. So we're here to bring me down. Oh my gosh. We're here to put me down. You know that you began at loss. You'd be like, oh, I think I missed the answer. Like being shocked like you missed it. Stop exposing me, bro. All right, whatever, whatever. We made it to the diner, okay? So I'm gonna surprise you today. I don't think I'm getting chocolate chip pancakes. What? I think I'm getting blueberry. Blueberry slaps. Blueberry does slap. It really does. Tastes like it'll make you want to slap your mama. Period. That's right. And I think I'm gonna get a side of bacon with that. Maybe some toast. Okay, we're feeling a little froggy. Froggy? Yeah. What do you mean?  All right guys, we'll see you inside. Blueberry pancakes for the win, Janice! Told you I was switching it up. I didn't even get what I said I was gonna get. Really? I said I was gonna get what? Blueberry pancakes, toast and like sign up. Bro, I got blueberry pancakes with some home fries and apple juice. Yeah, but you got what you said you was gonna get. What are you talking about? No, cause I said I was gonna get like toast and whatnot. I don't even know what I said anymore. I don't care. Guys, he literally ate like this much. All right, see, they already know I have trouble finishing my pancakes. This is why I don't even show you guys anymore. Cause you didn't even eat. Guys, I like pretty much clean my plate. Yeah, you did. You might as well have licked it. That's how clean your plate was. Anyway guys, so we're done here with breakfast. Now we're gonna head over to Petco PetSmart. Again, whatever it's called. And we're gonna get Nenis some stuff. We're gonna spoil him and we'll see you guys there. Is it me or did they change the way the sign looks? That's a different logo. They definitely did. Right? They changed it. This is why I began to mix up, man. They be changing stuff without telling me. They gotta run that by me first. Okay, well who gotta tell you? The city? Whoever. Okay. Maybe the dog gonna count on the logo. All right, I'll make some calls, I'll make some calls. You do that and you make sure that they contact me. And then I'll have my people contact your people. Okay. All right, sounds good, let's get in there. All right, Janice, so what are we starting with first? We are starting with toys. He already has enough. Sorry. Thank you. Let's go. Bro, but he has like five. I wanna hear it. All right, sorry. Oh my God. So I want to get him one of those pulley toys because at night he gets really hyper and he likes to play.  So maybe we can have a pulley one so he doesn't grab on the pull part. It's nice and juicy. Doesn't. What should we get him and put it down? I don't know, what about that blue one? What's that over there? It looks like a squid. What is that? Oh, I don't even know what this is. I don't know what that is either. It looks like a squid. Looks like a rabbit. Yeah, a rabbit with those long legs? I think not. Oh no. Look, look, look. This stuff is coming out. Nope, nope, nope. Nope, nope, nope, nope. Didn't he used to have this one? He used to have one. He used to have one. Look, oh yeah, he did. What happened to this one? I think it broke. Did it? I think Bear broke it. Of course Bear. What do you think about this one? All right, as long as it's not shedding. This one's not shedding, I checked. All right, so let's do that one then. Okay. Let's see, should we get him another one? Is it squeak? Oh, he's gonna love this one. Yes, sir, squeak. Ooh, yay. All right, so we'll get that one and I think that's it. He has enough. Oh my God, all right, fine. Maybe we get him another one of these. All right, so what color is it? Yellow or the green? Green and green? I guess, I don't know. You're taking charge here because I feel like if I say something, you might hit me. Because it looks like him. All right, fine.  Instead of I feel like if I say something, you gonna hit me.  You've been coming at me crazy. I don't know. I give you the look. The look is enough. That's scary enough. Exactly. I'm scared for what's after the look. No, I don't think Nene is yellow. I just think that he has like a cream beige color. You know what I mean? You got a cream beige color. What is that supposed to mean? I don't know, bro. But anyway. He gets it from his mama. Again, he got two toys. All right, onto the treats. Mother Janice over here doing her thing, looking up ingredients and whatnot. What are we dealing with over here? What are these? So these are animal cookies. Animal crackers for the little Nene. Yeah, but I'm looking at the ingredients and everything looks good. It's like wheat flour and stuff like that. I feel like it's not super healthy. So this may be like an occasional snack. If I do get it, but we'll see, we'll see.  Yes, he loves those. I think that's in the other aisle. But we're gonna get that. Yeah, let's go get that first. I have to think about this. The only thing that they had that we usually get on one of these birthday cake treats, other than that, we had to switch it up a little bit.  I'm very curious about that. But Janice over here insists on getting it. Yeah, cause he likes chicken. So I wanna give him something, chicken. I'm sure he'll like whatever you give to him, mostly because he eats everything. But then we have these right here. These are salmon. I usually get the chicken flavor, but we're gonna try salmon now. It's supposed to be really healthy for dogs, but I was a little bummed out that they didn't have the chicken ones.  And I think now we're going ahead over to make his little collar. So I'm excited for that. Let's do it. All right guys, so we just made it back home. And Janice over here is in her feelings because over here you can see his little paw prints from this morning. And obviously he's not here right now cause he's getting his surgery, but Janice just got in her feelings real quick. I'm trying really hard not to cry. It's all right, we're gonna get a call very soon and we'll be able to pick him up sometime later in the afternoon. It's not soon. It is soon. Just don't think about it. It's 11 o'clock. They said four. Don't think about it. I'm not thinking about it. I need a distraction. I need to be doing stuff all day. So I don't think about it.  Yeah, I'm gonna go home. I'm gonna call my dad. All right guys, so Janice is currently sitting on the couch talking to her dad right now. I'm kind of like just leaving her alone, letting her be in her zone with her dad cause he's got her distracted, which I actually like. But just a few minutes ago, the vet actually called me when I was over there with her. Surgery went well, thank God. I wanted to get the phone call on camera but we were like so eager to hear what happened, how the surgery went, that I just picked up the phone. But overall the surgery went really well. He's waking up from the anesthesia just fine. They removed all the cysts. He also got neutered and they also eclipped his nails as just part of routine whenever a dog has surgery. So overall everything went great. We should be able to pick him up in about like five or six hours from now. I'm super excited to go see my little boy. But yeah guys, just wanted to give you a quick update. We'll pick up the camera again when we're on our way to go pick him up. I can't wait to see him guys. So this is the moment that I have been waiting and like not excitedly waiting for. Dreading. Dreading, that's the word I was looking for. I have been dreading this moment since I found out that he had to get surgery because I don't want to see him in any pain I don't like him. He might have been the worst thing already. He already went through the surgery. I know that but it's like this is, I feel the healing part of surgeries is the worst part. I don't feel like that surgery itself is the worst part. I feel like the scariest part was him reacting to the anesthesia and how he would wake up and all that which the vet said that he woke up perfectly fine. He's waking up comfortably. You know, he's chilling right now. I know but still like I just don't want to see him hurt. That's all. Brace your eyes cause you're gonna see him. You know, obviously with like stitches and stuff like that. But everything went well. So I mean that's the positive. That's the bright side about everything. Yeah, I know that everything's fine.  Like you don't. So that's really all that it is. Like I'm happy that everything went well and I'm really like trying to be positive. And I think I've been pretty positive so far. So I feel like this is just the moment. I just hope my baby still has his personality. I don't want him to be so down and gloomy and in pain. How would he lose his personality? Cause I'm just saying like I don't want him to be gloomy and like upset. He's gonna be all tired and stuff. He's from, he's off the anesthesia. So it's like, you know, he's not gonna be himself for a couple of days. I don't know, but let's go pick up my baby. All right guys. So we got Mr. Nene. As you guys can see he is okay. He has a couple of stitches on this side that are pretty crazy. You probably can't really see them, but yo, Janice didn't cry. No, I saw him when I was just like, his incisions are amazing. This is what I mean when I say, I wanted him to keep his personality. He, the doctor said that he was like freaking out cause he wasn't home. And I'm like, yeah, that's my Nene. Yeah. Now he's like, guys, he's gonna be like really like groggy and drowsy for like the whole night.  But yeah guys, everything went great. Now we just have to watch him. No hyperactivity for like 10 days. And we have to bring him back in 14 days to remove all the stitches, but they did a really clean job. I'm happy that they didn't make any like bald spots everywhere other than like the big one on his leg on that side over there.  You gotta shave that, but everything else is really great. We're really loving this vet. So like I said guys, right now we're on the way home. I'm gonna put the camera down now. So I'm not driving and recording at the same time. So we'll see you guys back at the house. So he's doing really well. We just got back to the house obviously. He just went up this little ramp that we have for him and he just jumped up and we're like, okay, he's feeling great. These are the stitches right over here. This is the biggest incision he's gotten. That's what it looks like. Stitches are really clean though, nice and tight.  I don't know if you guys just saw that. One right there. And he also got neutered down there, but we're not gonna show that area too much for obvious reasons. But overall, he's doing really well. He kind of wants to roam around the house and stuff. So at this point, I think we're gonna end the vlog here. So that means now it is time for today's post notification shout out. Today's post notification shout out goes out to Sandra too. Shout out to you girl. Thank you so much for the love and support. If you guys wanna post notification shout out, all you gotta do is like, comment, share and subscribe. Comment down below, send positive as well again guys. This was a very tough day, I'm sure for Blooper. But with all that being said, we'll see you guys in the next video.


Government shutdown goes into effect, two generals are relieved, and female marines complete the first week of infantry training. All of that coming up next on The Core Report. Welcome to The Core Report. I'm Lance Corporal Allie Beiswanger. And I'm Lance Corporal Clayton Philippovic. As you probably already know, the government shutdown went into effect October 1st. While many civilian government employees are temporarily furloughed, military personnel will continue to perform their regular duties with pay. President Barack Obama released a statement following the shutdown, ensuring the success of Americans military. I'm going to make sure you stay the greatest military in the world, bar none. That's what I'm fighting for. That's what you and your families deserve. For more information, read the story link below, or check out Mar-Admin 512-13. Following an investigation, comment out of the Marine Corps General James Amos is forcing two generals to retire for their failure to prevent a fatal security breach during the 2012 Camp Bastion attack. Two marines lost their lives, eight personnel were wounded, and six aircraft were destroyed. The investigation found that Major General Charles Garganis and Major General Greg Sturtivant didn't take the necessary steps to protect against an external attack. General Amos said, commandership is a sacred responsibility and the standard for general officers is necessarily high. In their duty to protect our forces, these two generals did not meet that standard. Last week we announced that the first group of 15 female marines began infantry training at Camp Geiger, North Carolina. As promised, we sent a team to follow the training. During the first week, the marines completed a combat fitness test, a physical fitness test, a high intensity tactical training assessment, and a 5K hike. All students are held to the same infantry training battalion standard, which has not changed. By training day five, one male and two female marines had been dropped from the cycle for failures. Since the first half of the infantry course is similar to the Marine combat training all non-infantry marines must complete, instructors expect an increase in drops across the board in the second half of the course. We will be sending a team to give the updates during this time. Remember, you can catch up on everything else going on in the Corps by logging on to our official social media sites at YouTube, Facebook, Twitter, Flickr, Pinterest, and Instagram. The links are in our video description. Thanks for watching guys, we'll see you next week right here on the Corps Report.


Another question we've had come in and I've personally myself I've seen this working at a university is what happens if I just forget a Document am I going to be told to go back home into my country or what would happen if say I forgot my I-20 or something like that Happened, I think maybe that bends a little bit on the question used to answer it, but if you forget your I-20 you have a valid visa and On primary the officer will refer just to second there on second there That's where CBP will actually issue the I-515A and you can bring that I-515 to your school as an official and they'll work with you


to the platform backend update for September 4th 2017. My name is Dao Man and I am the platform backend lead at GitLab and today I'm going to tell you quickly walk you through what my team has worked on the last five weeks and what our plans are for the next five. So to kick it off in the last five weeks one thing we did which went unnoticed for most people was that we soft launched translate.gitlab.com. This is the platform that's going to be used by our community members as well as ourselves and any customers that might be interested in helping translate GitLab. We haven't announced this is a big thing yet because we're still some kinks we want to iron out there's some things some processes we want to document there are some things we want to automate to make it a little bit easier for us to get these translations back into GitLab for example. But this is something that Bob has been working on for the last couple weeks and something that crowd in the party that actually runs the application behind translate.gitlab.com has been working on as well they've been very helpful with us we've been working with them to remove some performance issues and basically to get this up and running smoothly for a project like GitLab. So if you check out the status and next step links there will be a little bit more about what has still what still has to happen before we are going to announce this is a big thing but of course the plan is to allow some announces on the blog at some point as the canonical place where everyone who wants to can help GitLab be translated into more and more languages. Of course that's only part of it we also as GitLab need to make sure that all new features we develop are externalized from the beginning which means that people can start contributing strings and we are continuing to slowly translate you know new pages externalize new pages and make them ready for translation. So again thanks Bob for working on that over the last couple weeks. Then on august 22nd we released GitLab 9.5 a couple notable things first of all GPG commit verification this is a really awesome feature that we have been we have wanted for a while and it was pretty much entirely contributed by Alexis Rigel from Siemens it is my understanding that Siemens allowed him or at least you know authorize him to work on this GitLab submission this GitLab contribution for a while because it's something that they were interested in and he did a great job he worked really well together with Dimitri and some of our Dimitri Zapargetz being our CTO as well as some of our UX and front-end people to get this done so that was one of the headliner feature for 9.5 and it's always nice when a headline feature is community contributed instead of built by the company. We also introduced a flow for buying a trial license inside the enterprise edition which means that for new customers it's now much easier to try out enterprise edition if they install it they will be the admin who signs in will have the option to buy a trial license right from inside EE previously they would need to separately go find our customer app and buy a license there or no not buy in this case but download it there and upload it into GitLab mainly and until then GitLab would just be very unhelpful and refuse to do anything now it has been streamlined and it's a lot easier for customers to get started with EE this way thanks Ruben for working on this as well as Oswaldo who is not in the platform team but he did help with this as well as well as some UX people because of course a lot of work needed to be done in the customer app as well as in EE to make this a great experience for our users then third we have mirror repository over SSH we have had the mirror repository feature in EE for a while but before now it really only worked well when you were using HTTPS to move data between the two Git repositories you could already use SSH SSH with some tricks but it wasn't possible to you know provide a specific to pretty much see a specific public key inside GitLab that you need to upload to your other instance to allow this to be a secure SSH connection and now this is an option check out the link if you want to know more about exactly how this works but this is going to simplify a lot of things for people who don't want to have to configure a username password configuration inside GitLab that will always be stored in GitLab in order to use repository mirrorings that will be great of course there's a lot more that we did in 9.5 both on the side of my team which you can find if you click the more link and of course the entire company did a lot of stuff that is not included here which you can find if you go to the GitLab 9.5 link which will link straight to the blog post that will you know tell you about all of these new things then a couple days ago on September 1st we launched GitLab.com feature plans we already had plans in GitLab.com for a while but they basically just affected how many CI build minutes you had available to your group or to your users projects now we extend this with feature plans bronze silver and gold where the plan you are on actually determines what features you have access to this roughly maps to what is the case for community edition enterprise edition and enterprise edition premium and a future enterprise edition ultimate but for GitLab.com this works in much the same way with of course some caveats where for example public projects get everything for free but all of that can be found inside the blog post behind that link I would a lot of people worked on this for many many different teams it was really was a cross-functional effort and I would like to specifically thank Ruben, Tony, Nick and Bob for my team who did a lot of great work over the last couple months to get this out then we are going to the next five weeks so first first like I briefly mentioned we are going to further improve our IATN, IATN being internationalization tooling as well as translate.gitlab.com we're going to automate some more stuff we're going to write great documentation to get people up on running quickly if they want to contribute a new language or if they want to contribute to an existing language and then of course this will also be announced on the blog etc. Next we are going to finalize GitLab 10.0 on September 7th and release it on the 22nd with a number of notable features a big one is the option to configure object storage for LFS objects this means that the LFS files that people upload into the repositories will not necessarily be stored on the actual disk but you can configure it to store them in object storage like S3 or comparable products instead which means that you don't need to buy a huge hard disk which you can leverage a huge hard disk that Amazon already has or the ones that you set up yourself for this instead. We are also going to automatically reject commits that have missing LFS objects this requires iterating over every incoming Git object and checking if they reference an LFS object and then verifying that the LFS object actually exists this will make it a lot harder to forget to push LFS objects or for example to check out a project without having LFS installed and then making some changes to the project that are not applied correctly because you don't have an LFS locally and we're also going to add automatic pruning of unreferenced LFS objects we currently already have a feature where when you where when a couple of projects all point to the same LFS object of course the LFS object will only be actually stored on disk once and then when all of these projects for one reason or another get deleted then the project gets the object gets cleaned up as well but there's currently no way to get rid of an LFS object when the commit it was in or the branch it was in gets removed or the commit gets overridden using a force push in this case is the LFS object will linger around even though there are not actually any blobs inside the repository anymore at the reference that LFS object this is also something that we are working on for 10.0 there is a chance that it will strip because it's quite hard to get this to work in a performance fashion this is something that we have been working on as well next we are doing a proof of concept GraphQL endpoint we are not going to roll out a full GraphQL API for GitLab yet but we're making our first start kind of trying out how GraphQL would work for GitLab and we're starting with a specific endpoint that's around merge request data and the basically basically provides all of the data that the merge request widget the widget that has the merge button the remove source button the approve button all of that stuff all of the data it uses it will now be able to get from the GraphQL endpoint we are not going to actually replace the existing implementation of the merge request widget yet or at least we're not going to get it to work with GraphQL just yet because there are some license problems legal problems in the licenses that the javascript GraphQL library uses we are going to ship the back end of this which will pretty much set GitLab up to start building more and more of these GraphQL endpoints and to start using them for you know GitLab components in the future instead of writing highly specialized APIs as we have been doing in the past there are also going to be various performance improvements including but not limited to those involving project creation project export commits group member creation if you check out those links or the various performance improvements link you'll see a little bit more informational for doing there most of this has already been merged so these are definitely improvements going into GitLab 10.0 of course there's also various bug fixes related to but not limited to subgroups mirroring and passwords specifically a password flow when an admin creates an account but they are presented with a password form when they didn't expect to that kind of stuff i'm not implying that passwords don't currently work because that would be a much bigger issue and of course there's a lot more that you can find out at more link that we are working on for 10.0 and then in five weeks it will be really close to the release of 10.1 so that's when i'm going to be telling you all about that and in the meantime i'm looking forward to working on 10.1 and making stuff to tell you about in five weeks have a great rest of your day everyone


So I was all set to start work on a video about why Nintendo made Ganondorf so attractive in Tears of the Kingdom when suddenly a child sued Nintendo for loot boxes in the mobile game Mario Kart Tour. And just like that, I knew what I had to do. Dig through court documents to find out more delicious details of this fascinating case.  But dig a little deeper, and this is part of an ongoing war to try and force legislators to prevent predatory and unscrupulous games industry practices involving gambling mechanics in games aimed at miners. So the version of the story you may have already heard. The plaintiff in this case, who has not been named for legal reasons as they're under age, was allowed by their father to play Mario Kart Tour on a smart device between 2021 and 2022. Without really knowing what they were doing, the plaintiff then managed to spend $170 buying rubies so they could use the game's spotlight pipes to try and win additional in-game items. Spotlight pipes were, at the time, fairly typical loot boxes. You got one random prize of varying quality every time you used one, but the odds on the rarity of these prizes weren't disclosed, and you had to buy the rubies for real-world cash. Now, I hope I'm explaining this right, because I haven't personally played Mario Kart Tour. I don't really do Nintendo mobile games for fear of this exact scenario, so apologies if I'm bundling the specifics of how spotlight pipes used to work. Now Nintendo has since removed spotlight pipes from the game following public backlash. You simply buy the items you want from a store with rubies without all that messy gambling, although you still pay real-world money for the rubies. A lot of parents have ended up in the situation where their kid has managed to spend money on a mobile game by accident. It's fairly common, and you hear plenty of stories of families fighting for refunds to varying success. By US law, children have the right to reaffirm or cancel any of these purchases, which is a fact that Nintendo and other games companies don't exactly go out of their way to publicise. I certainly didn't know when I started researching this video, but then I, A, don't live in the US, and B, don't let my kids play mobile games with microtransactions. In this case, according to court documents, the parent, Bruce Owls, also didn't know that he could ask for reaffirmment. So instead of begging Nintendo for a refund, he has supported his child in taking Nintendo to court. And oh wow, does the prosecution not mince words when calling out Nintendo's shady practices. Here are a few of my favourite excerpts from Exhibit A. The pipe loot boxes offered in Mario Kart meet the definition of gambling, as set forth by a multitude of gambling statutes and regulations and rely on the same predatory practices designed to induce consumers to spend money on games of chance. Miners are especially susceptible to these addiction enhancing elements of game design. The FTC has given some examples of dark patterns deemed deceptive. This includes grinding, or making the free version of a game so cumbersome and labour-intensive that the player is induced to unlock new features with in-app purchases, which the FTC deems as coercive action. These intentionally designed omission-based dark patterns of grinding and pay-to-skip, spotlight pipes limited offers, etc., in the Mario Kart tour game have been deemed by the FTC to create coercive action and consist of unlawful, unfair, or deceptive acts or practices, especially when aimed at minor children. Defendant, Nintendo, knew or should have known that its omissions regarding the in-game purchases were false, unfair, deceptive, or misleading acts or practices. Especially after the dark pattern design of the Mario Kart tour game removing the loot box pipes from its Mario Kart tour game. But Defendant has nonetheless failed to offer to provide plaintiff and the other members of the class and subclass refunds. Defendant's conduct described herein constitutes an unfair business practice because it violates public policy and is immoral, unethical, oppressive, unscrupulous, and or substantially injurious to consumers. Wow. See, that is why you hire a good lawyer for a case like this. And that, that is the hidden secret in all this. The lawyers involved. The plaintiff in this case is represented by the Chicago-based McGuire Law, a legal firm which is also representing a child who is suing Take-2 Interactive for their loot box practices. A quote from that case reads, Defendants, Take-2s, unfair, deceptive, and unlawful practices, including illegal gambling practices, deceive, mislead, and harm consumers. Plaintiff and other consumers have been injured as a result of Defendant's practices, including but not limited to having suffered out-of-pocket loss. Now, I'm not a lawyer. I'm not a legal expert, but I do see a pattern here. McGuire Law has a pair of court cases taking place in different US states involving an underage child suing a major game developer for loot box gambling mechanics in their games. Both cases make reference not just to the specific children involved, but to a wider class of consumers who have suffered as a result of game developers' actions. To quote the Take-2 case, On behalf of herself and all others similarly situated throughout the United States, Plaintiff seeks to redress for damages and other relief arising from Defendants' deceptive and unlawful conduct. Essentially, these two cases are part of a wider effort to create legal precedent banning the use of gambling mechanics in games played by children. This being the case, while you might dismiss these kinds of reports, why not just watch what your kid is doing on your tablet, etc etc, the lawsuit against Nintendo is an attempt to make gaming more fair for all of us. But that said, yeah, definitely watch what your kid is doing while playing any video games. Personally, I find it's not just helpful for credit card security and online safety, but it also means that I can be more involved in my daughter's hobbies, and that's a good enough reason by itself. That is the moral of the story for today. Thanks for watching.


The round-dodge city and in the territory on West, there's just one way to handle the killers and the spoilers, and that's with the U.S. Marshal and the smell of gun smoke. William Conrad, the story of the violence that moved West with Young America, and the story of a man who moved with it. I'm that man, Matt Dillon, the United States Marshal, the first man they look for and the last they want to meet. It's a chantsy job, and it makes a man watchful, and a little lonely. I'm here in bed so early. I'm not in bed, Doc. I'm just resting. Oh, I did that, man. Oh, I see the cost of governments going up again. Well, why don't you say that? The souls of your boots. They're worn almost through. I don't care. That's better. Aren't you feeling good? Sure, I feel fine, Doc. I always lie in bed till noon. Well, it just doesn't look right for you to be like this. Oh, for heaven's sakes. What's the matter now? It's cold. The coffee's cold and the rattlesnakes belly. Don't drink it, sir. And it's no better hot here. No man like I was saying a man in your position should have more to do than just lie around. Maybe I'm just tired, Doc. Oh, now don't try to tell me it was brought on by upholding law and order all night, because I don't want to hear about it.  Well, then sit down and rest. Yes, hey, aren't you going to ask me what I was doing? No. Well, I spent the whole night working for four dollar fees. Oh, it must have been somebody who didn't know you. They knew it was Jeb Dorn. His wife had a baby girl. Jeb, huh? He was hoping for a boy, as I recall it. And that's what worries me. Oh, why? He refused to pay me. No wonder you're tired. Hey, hey, hey. What's your thing now? Well, who's this poster on? It says right there, doesn't it? Yes, it does. Wanted? Get her alive, Jack Pargo, for the torture and subsequent murder of... This man is noted for armed holdup and is believed heading in the general direction of Missouri. Kansas. Or Nebraska. He's a mean-looking devil, isn't he? Well, I can see that he will certainly find his comeuppance if he sticks his head in Dodson. Well, I'll tell you, Doc, I'll worry about that if he comes here. Oh, that gives me a nice, safe feeling. Marshall, here is a... Yeah, yeah, I'm the Marshall. I say Marshall Proudfoot, hereabouts is a... Marshall Proudfoot? Huh? Yeah, no, neither one of you... I'll say neither one of you ain't the Marshall I can tell. I was Paul, I didn't know him anywhere. Uh, Doc, go find Chester, will you? Sure, man. No, no, no need to get up, just come see my boy, Marshall Chester Proudfoot. Made good somehow, he did. Chester Neverworld, one of my brightest boys. Eleven boys I had, I remember. See, I ain't your hand here yet. What's your name, sonny? Dylan, Matt Dylan. Dido? Ah, a funny name for a man. I knew a man one time had the name Hergrove. Hergrove. I thought that was the funniest up till now, but Dylan...  Who's that fella? Well, that's Doc Adams. Nice to tell you, sir, saying something is a... I said it's nice to know. Now, my name is Wesley Proudfoot. Sir, the Marshall turns out... Yes, sir, eleven boys I had. Chester was no word near the brightest. No, sir, he'd rate about number nine there. That's very interesting, Mr. Proudfoot. Chester bordered on being ignorant, I'd think. I can't imagine how he ever got to be a Marshall. Chester Wesley Proudfoot. Marshall of Dodge City, Proudfoot. Look, Mr. Proudfoot. He named all them boys with the middle name of Wesley. After me, he did. I hoped at least one of them would mount something like me. I'd say name-wise. It's Adams. Doctor Adams. Doctor Adams. Horse or people. What? It matters to you. I say, do you see a doctor, horses or people? People. Oh, it's too bad for you. I wouldn't ever let a people doctor work on me, and I got a great many things wrong with me, too. Hey, where's Chester? He's out getting the mail from him. Well, good for him. He's got spunk. Probably running down some of them bad men he always writes about. You have an assistant named Dylan working for him. What have become of him? Dylan, that's me, Mr. Proudfoot. Matt Dylan, that's me. Oh, yeah. Well, you'll do a fair job, according to Chester. Says he can usually depend on you. Well, that's very nice of him. Look, Mr. Proudfoot, maybe you should know something. Hello, Don. Chester, there wasn't too much mail, Mr. Donk. I got it, Chester. What? Chester, you've got company.  That's Chester. That's the marshal, Proudfoot. Paul. You know, Mr. Dylan, I just... Paul, aren't you, Chester? Yeah, that's him, Mr. Proudfoot. Ah, you fatted up, good deal, Chester. Your assistant here looks better than you do. I'd like an explanation. Is there a fact so without it, Chester? Mr. Dylan, Doc, I... Oh, Paul. Some folks, I guess, think that stamps are just for licking. And some go in for that flatly stuff. You know, looking for misprints and hard-to-get ones. But me, well, I just collect them for fun. I learn a lot that way, and maybe you can, too. Now, that's cause our United States stamps all got the stamp of history on them. If you got a minute, I'll open my album here and I'll show you what I mean. Let me see here. Ah, now, here. Here's a 4% one the post office put out in 1962 for the 75th anniversary of the Association of State Universities and land grant colleges. I ain't had any of that higher education myself, but I know it's mighty important in making your way these days, and you're never too old to learn. No, even from stamps. Found out from this one that A. Blinken signed the Land Grant Act into law during the Civil War. Now, that act still gives the money from sale and use of public lands to help make 68 colleges and universities some of the biggest and finest we've got. And, seeing as how they turned out 25 of our 42 live-in Nobel Prize winners, I guess you could just say it's paid off real good. What are you going to do about Matt? Do about what, Doc? Chester, telling his father that he's the Marshal. What can I do? I'm not going to let him get by with it, are you? I don't know, Doc. No, Matt, no. Let me by. No. An assistant doesn't make too much, you know. Easy, Doc. Hello, Doc. Matt. How are you? Doc, you're looking pretty strange today. How come? Tell her, Matt. You tell her, Doc. You're the one looking strange. Well, come on. Somebody tell me. Sit down. Thank you. Have you seen Chester, Kitty? No. Why? Well, we may never see him again. What? What happened? Not much really, but I'm sure he wishes he was dead right now. What's this all about? Chester's father came to town today. Well, that's a terrible about that. He thinks Chester is the Marshal here. What? Yeah, that's right, Kitty. Chester wrote to his father and he probably stretched the truth a little bit like we all do sometimes. Oh, no. Well, where are they now? They're at the Dodge House. He's getting the old man a room there. I never saw Chester look so scared in my life, Kitty. You should have seen him. He grabbed his pawn. He lit out of the office like his coat was on fire. Don't be hard on him now. I'm not going to be hard on him. Well, his father must be pretty old. Oh, he's older, I guess. I can't hear good and he can hardly see. But he's a bright old father. Well, you can't let the old man be disappointed, Matt. Well, what would you suggest that do, Kitty? I don't know. Just don't hurt him. That's all. You're not going to hurt him, Kitty. I don't care if the old man thinks Chester's a marshal. Matt, we should think of something to make Chester look good while his father's in town. Yeah, I heard the old man tell Chester that he was only going to stay for a few days. Oh, see, Matt, maybe you could lie low for a while. I wouldn't mind that. I'd need a rest. Hey, I got it. Why don't you get somebody to pretend to hold up and then let Chester play Marshal and take him in? I'd be too loose when his father leaves. Kitty, I couldn't do a thing like that. Well, something's got to be done, Matt. Yes, did you? I could put you to bed, Matt. What are you talking about? Yeah, you get sick and I'll examine you and say that you've got a rare blood disease and you have to go to bed for a few days. Get my work, Matt.  No, we'll get Mars grimmick to stage a fake hold up, you see?  You're the one with a rare disease, Doc, and it's not in your blood, it's in your brain. I'll do it, Matt. You got to. No, I don't got to.   Oh, Matt. Well, I'm going back to the office. Oh, sure, go ahead. Yeah, go ahead. Ruin an old man in his last days. Um, what do you think, Doc? Man, I... Old Matt will come around, all right, Kitty. I'll go talk to Mars grimmick and have it all set. You're a bit kind of early, didn't you? Ain't but four o'clock.  You can do that, you and Chester. I say, where is Chester? Saying something? I said, where's Chester? Oh, yeah, I like that. Hurt me your pant when you bell her out like that. It's got a pretty big voice on you there, Dylan. What's the matter with you? Uh, feeling poorly are you? I feel terrible. Ah, too bad. Chester ain't feeling too good neither. I'm on my bed over at the Ruin House all day.  People will be up the creek with both the Marshal and his assistant in bed. Ooch over there. I say, ooch over there, let me take a look at you.  Tell everything about how a man feels by looking to his... Look at me, Dylan. I can't help looking at you. That's it, that's coming. Yes, sir. You've got bad eyes there, Dylan. That one in particular. You've got a good voice, but bad eyes. Reminds me of Chester's Uncle Hector. Last time he looked all slack-jawed like that, he died the next day. Huh? What say? Nothing, I didn't say anything. Oh, thought you talked. Yes, sir. I reckon that's where Chester gets all his, get up and go. Well, some different though. Hector fought again the law, Hector did. Ever seen a man stirred up again the law all the time I go? Have you had your dinner yet, Mr. Price? Oh, indeed, he was a winner. You're right there, won all his battles. Killed two Marshal's, Hector did. Killed him dead. Good thing Chester's on side of the law. Man, it's a peril I've got ought to be on the side of the law. Yes, sir. Hello, Mr. Profit. Oh, you're here.  Better go get a horse doctor and get him straightened out. What are you doing in bed, man? I'm in bed because I'm sick, Doc. Did you ever hear of anything like that? You're sick? Uh-huh. You are, man. Oh, see, that's fine. Yeah, well, I figured you'd think so. Do you have any favor and take Mr. Proudfoot out to dinner? Anything, just get him out of here. Yeah, sure, Mac. You're much older. See, your eyes look kind of beady there. Yeah, well, we've been through all that. I didn't know that I'd say that you had a fever.  Doc, would you go right now? Yeah, okay. Oh, sure. Mr. Profit, you come with me. Come with me, Mr. Profit. I'll take you to dinner. Dinner? Oh, no, too early for dinner. I'll see you later, Mac. And I'll let Kitty know you're with us. Oh, fine, Doc. Good. You let Kitty know I'm with you. You just go. Yes, sir, Adam.  Let Kitty know I'm with you, but in common. And yet they're each one of a kind. Take, for example, Chicago, Illinois. The land of the Spiegel catalog and the Playboy Bunny Beacon is a totlent town. And at the summer music festivals in Grand Park, the price is right. Standing at Marshall Field on State and Randolph, you're on the windiest corner in the world as your body braces for the blast. The colorful neighborhoods of the west side are gone to urban development. But the University of Illinois is getting a new campus there. In theater, there's the second city on the near north side or the theater on the lake in Lincoln Park. Shopping in the suburbs offers Old Orchard in Skokie, Randhurst in Mount Prospect and Oakbrook near Hinsdale. Chicago can't win them all, though. In 1948, the tribune said, Dewey defeats Truman. And in the fall of 66, the convention center burned. But if your hometown is Chicago, you already know this. We only wanted to remind you, it's still there. I've wasted a half hour looking at all the eating houses for him. He's got Chester's father with him. I gotta stop him. What's the idea that you and he had? What do you mean, full idea?  Kitty, I was in bed because I really was sick, and I still am sick. Have you and Doc lost your senses? Well, we're just trying to help. Chester, that's all. Now, look, what if somebody else sees that hold-up mask gimmick at stage, and how do they know that he's just playing games? Doc and I aren't going to let anybody get hurt, Matt.   Chester and his father, up at the Dodge House, in exactly three minutes from now, Moss Grimmit is going to rush up there and say there's a hold-up at the delivery stage.  What's that? I don't know. It's not time yet. Oh, come on, Doc. You can watch the fun you started. Yes, I'll have fun. Come on.  Now, Matt, now take it easy, Matt. Chester, hurry. Chester just shot a man at the Dodge House. Good lord! Please, move aside. Stand there, Matt, Matt, wait. Look, Chester's sitting on somebody. Chester, what are you doing? Get off of that man. Doc, check that one line over there. I will. He shot and wounded one fella, and we subdued the other one. All right, Mr. Paul. Chester, will you get up? He tried to kill me and Paul. Get up, I said. He's unconscious. Oh, Matt, wait a minute. Look here. Look at this man. It's Jack Pargo. What? You're the man on that wanted poster? Yeah, that is Pargo, all right. Matt or Dylan, our fellow friend of yours is a... He tried to hold up the hotel office here. No, Mr. Proudfoot, it's not a friend of mine. Huh? What say? Anybody catch that call, then? Chester! Chester! There is a hold up at the delivery stable. Moss, go home. But Doc told me to.  Yeah, forget it, Moss. Forget it. We've had the real thing, right? Well, goodbye, Moss. Yeah, sure. Goodbye. Goodbye. Goodbye. Notice something here, did you, Dylan? Chester was right on the spot. He was. That's the reason he took my bed for so long. Uh-huh. He got an instinct for these things. Chester has put him right here on the spot for this hold up. There's a reason for everything. Yeah, well, there's a reason, all right? Mr. Dylan? Mr. Dylan, I can explain all this. No, Chester, you and your father take care of things here.  Don't count on me taking care of things, Dylan. I'm leaving on the morning stage. Now I'll solve my boy an action. Yeah, well, all right, Mr. Proudfoot. Goodbye. And good luck to you. You wait right here a minute, Pa. Mr. Dylan? Yeah, what? Mr. Dylan, I... Mr. Dylan, I can explain. You don't have to, Chester. But yes, I do have to explain. That's where I've never been so humiliated in all my whole life. I've been thinking about it all day, Mr. Dylan. I never wrote but two letters to Pa. Well, maybe I did stretch a couple things at the... Pa, he... Well, Pa, he put it all together and made me out more important than what I am. But I'll set him straight, Mr. Dylan. I'll tell him the truth and I'll do it right now.  Yes, sir, Mr. Dylan. As used, I generally find a colorful example in some speech of that old political character, Elijah Cuddlestone. For instance, now, I admit, I say, of course, I'm a grassroots candidate. I work from the bottom up. That is, I get down to the basics of a matter, down to the grassroots. Now, I want to know how I... I mean, you're my people and I insist on knowing how you might be affected. That is why you elected me because I am one of you and it's like I say, I am elected by you and working for you. Well, getting down to grassroots seems to be what politicians and office seekers report themselves as doing most anytime, but more especially, preceding an election. It's a folksy American phrase that simply means getting down to the underlying principles or basic facts of a matter and may be used at any time by anyone. The actual origin of the phrase is unknown, but its reported usage predates 1885. Produced and directed by Norman McDonald, stars William Conrad as Matt Dillon, U.S. Marshal. Featured in the cast were Parley Baer as Chester, Howard McNeer as Doc and Georgia Ellis as Kitty. George Walsh speaking. Join us again next week for another specially transcribed story on gun smoke. This is the United States Armed Forces Radio and Television Service.


I'm with Krishna Chakani of Chakani Group. This is the next chin. With me, he's going to tell us more about the NBFCs that Chakani Group runs. He's also going to talk to me about the family office that the Chakani Group is running and about how he's looking to diversify the business model to a unique one. He claims it's a unique one. We'll hear more from him. In your family office, what kind of investments are you doing? We're seeing family offices taking great flight in India, keeping in mind big businesses like yours, realize the need to invest in something more than just real estate and Google. How has your experience been? So experience is actually very good, especially with the digital shift that's coming in. A lot of disruptive technologies taking over family owned traditional businesses. So typically I've seen is a lot of family businesses are feeling left out because either of lack of knowledge, lack of expertise or old mindsets and old principles set up by the previous generation. As new generation, we are more risk-averse. We like exploring into new things and it's good to be backed by a family because there is still some runway that we can use or burn in order to grow. So that's what we are looking at. There are multiple things that we did traditionally. So I'm a Marwadi. So as Marwadis, we are known to be the money lenders of India. So that's how traditionally three generations back, my grandfather's father had started his initial business by lending money to various Marwadi community people. Slowly slowly we built up towards investing into market products. Then we started moving to gold, real estate as you rightly mentioned. Made it into debt products in India and globally. Technology investment actually started back in 2008 by my father because of one of his close friends did the first e-tax filing company of the country. That's where he invested and made a handsome return and that's where he pushed me to start looking towards technology. What are you doing in that? To start your NBFCs? So we typically operate our investments through an NBFC for the efficiency of a structure but we at the moment are looking at technology which are first financially, handsomely returning us the money, trying to see how safely we can help them grow and as well as incorporate them within our systems and then we see about how they are going to globally impact other sectors where we may be left out in case we don't diversify. FinTech obviously has been the main focus till now lending money has been the main focus. We just see what kind of a balance sheet it is and then start lending money without focusing on sectors but yes obviously going back now even entrepreneurs or borrowers have become smart. They need money from strategic people who can actually help them grow not just give them money. They need strategic investors not financial investors anymore. So that's where we see where we have expertise where we have network where our fathers for fathers have built their name goodwill and start using those companies to get them and leverage our network for their benefit as well. You're looking at investments in the global ecosystem also you're looking to get some technology into India? Yes yes so we are in a globalized world obviously India has a limitation on technology and talent so we cannot get everything in India so something like AgriTech is good in India but there's not too much of innovation so that's where we start stepping out to better places like Israel where we get to see so many innovative technologies they increase yields but ten times with a very mere investment just because of their research that they've done over years where we lack in so that's where we are looking to start investing into those kind of companies. The pace that you've picked up for family offices are you also looking to inspire other big families to set up the shop and do you see this as a phenomena happening in big family or businesses? Yes so you must have seen the big families like Agios just a very big example it's all over India these guys have suddenly shifted from traditional businesses to digital businesses in no time so obviously there are a lot of people in the tier two H&I category ultra H&I category family offices who have no clue of what's going on. Do you think that the disruption of tomorrow is going to be created by the Gennex leaders of our family offices and family businesses? That's true partly yes they will give platform to new technology to grow faster not only with their money but with their networks but yes disruption will only come in when new next gen starts diversifying starts innovating has a more open mind and not just be stuck a lot of Indian families are just stuck to their business because it's doing well but you need to have a foresight and that's what we are trying to build have a foresight for the next 50 years 100 years not only help families or your business to grow but help your environment also to improve


Live from San Jose, in the heart of Silicon Valley, it's theCUBE, covering AWS Summit 2016. Hey, welcome back everybody. Jeff Frick here with theCUBE. We are in Santa Clara, California at the AWS Summit, Santa Clara, 4,000 people milling around to get the latest and greatest on Amazon. And even more than AWS, really the ecosystem is really well-represented. Trific keynote by Dr. Matt Wood this morning. It's just really reinforcing the relentless pace of innovation that Amazon just keeps moving the ball down the field. They don't waste a lot of time. They just keep innovating, innovating, innovating. And they've really changed the game because of that relentless pace of innovation that everybody sees in the retail side at Amazon the store and Amazon the retailer, but really at AWS on the enterprise infrastructure space. It is relentless. So we're excited to be back here. Lisa Martin, great to be sitting with you again, our latest QPost, really glad to have her on board. And our next guest, we'll jump into it, Nelson Nahum, the co-founder and CEO of Zadara Storage. Welcome back. Thank you, how are you? Absolutely terrific. Thank you for having me here. Oh, terrific. So why don't you give us an update for the folks that aren't familiar with Zadara? Yeah, exactly. So Zadara is a storage as a service company. We do enterprise class storage with the same capability, reliability, security, performance of what you would call a traditional storage, but with the business model of as a service, with the agility of multi-tenancy where every customer has their own dedicated storage box, let's say. Right. And it's the paper use, it's connected to Amazon. Any Amazon customer can use our storage either as a blog or file. As well as we do with other cloud providers, number two and number three, and also we do on-premise. Also as a service, we specialize in storage, we are really good in storage, and this is what we do. Excellent. So you've got a great perspective because one of the big cloud topics is hybrid cloud, right? Everybody's talking about hybrid and some people would say it's just the old legacy people trying to keep one foot in, you know, as you move everything to their public. But you see both. You've got customers that have hybrid clouds, you've got customers that are using Zidara as storage on-prem, you've got people using storage through the Amazon connection. What do you see, kind of how workloads are shifting in points of view within your customer base? Yeah, great question. So, yeah, we sell storage as a service to enterprises and enterprises have data centers, they have cloud, they have different clouds, and they are moving many of the workloads to the cloud, but still, I think that the movement is not a completely shift. In some cases, some people are going the opposite direction. I think that people want to have the flexibility to run whatever they need at the time that they will need in the best place. Right. So we have customers that either started on-premise and move to Amazon or copy to Amazon or do DR in Amazon, and the opposite as well. We started with Amazon and they said, well, now we have a data center that we want to be able to move data back and forth. There are many workloads that make sense to do in public cloud, things like require a lot of CPUs at the same time, and things like that make sense to do in Amazon, and there are other things that are on-premise. And again, I think that the movement is that people decide, depend on the project, where to run and having more options is actually better. That's one of the themes that we've heard from some of the guests on the show today is flexibility, what really is kind of the phenomenon behind what AWS offers. I wanted to kind of explore the enterprise space with you a little bit. They launched last year the Elastic File System, really a direct target against the incumbent storage vendors, with whom you compete. They talked a lot about the enterprise today. They've got big enterprise customers, Salesforce, for example. Talk to us about what's different with Zadara Storage as a service, in comparison to those traditional incumbent storage vendors. Storage vendors, yeah. So one thing that is different is the way that we charge customers is per use. So instead of having the capex to buy the storage boxes, you just go to the console and provision the storage. It provision instantaneously. It can be accessed from AWS, it can be on-premise, it can be on other clouds. So this is one difference. It still has the reliability performance, security data, traditional storage, but because it is provisioning instantaneously, we can do this completely as a service. So the customer don't need to deal with buying hardware, they don't need to deal with how to manage the storage, how to upgrade the firmware, all these kind of things that belong to the previous history, they are not longer needed and the customer can focus instead of managing storage boxes in their own business. It provides more agility when they need, they provision the storage that they need and if you need to expand, you're expanding instantaneously, if you need to shrink, you shrink and you don't need to have these storage boxes owning and managing. So cost probably being one of the biggest standout business drivers that your customers are facing and as we kind of talk about the algorithm of innovation that AWS has been exhibiting for a very long time, that's one of the biggest things easier to adapt, deploy, manage and lower cost. Yeah, so I tell you my view regarding AWS innovation that is fantastic, frankly. And one of the main things that they really do well is the partnership and ecosystem. We were a really small company five years ago and we pitched our story to AWS, we were only seven people and they say, well, this is cool, let's work together. Even though we offer storage and they also offer storage, so I think that this is what makes AWS a great company, they are willing to bring partners that are sometimes competitors in certain areas. We are really good in storage, so we can provide really good storage services for AWS customers, it's good for AWS. At the same time, I think that the storage team of AWS having competition is good in order for them to continue to innovate. So I think that this help with innovation, it help us as a company because AWS is moving fast and we need to move faster. And they move fast because of us and we move fast because of them and it is a different dynamic that used to be the more traditional enterprise storage that as you know, it was very monolithic and observative. Yeah, the whole concept of the elasticity is fascinating really, it's one of the fundamental tenets of cloud beyond just the price in economics but to be able to elastic, and as you said, elastic means getting bigger as well as getting smaller depending on what the workload is. I think agility is the main thing, more than the pricing and so on. The agility means that people today in this global economy, they don't have rigid needs, they don't know if the Brexit will be good or will be bad, so having the opportunity to say, okay, if I need something, I go to a console and provision and if I don't need it anymore because of recession or whatever, I can decommission, it's huge for companies and then people need to do these calculations as opposed to, okay, it will take me a lot of capex and few weeks to get installed and if I don't need much, I stack with whatever I have. So I think that the agility and the capability to extend and shrink depending on the success is key for companies. I want to follow up on the other concept that you talked about, which is Amazon as a partner because clearly seven people feels like a pretty high-risk move to jump in bed with these guys that have a ton of engineering resources, a ton of capital. Yeah, and refer to as some of the customers. Right, right. But how did it impact your business in terms of your go-to-market? Because if it works, suddenly you're part of their marketplace, your exposure to a huge customer base, but then too, it's different, right? It's click-buying, it's not belly-to-belly sales, it's not a traditional way to go-to-market that you've got to kind of fit in. How did that work? And then how do you jive that with your traditional go-to-market and your traditional kind of non-Amazon customers? So I think that this, for us, was a blessing, I would say, because the fact that we are present in a marketplace anybody of Amazon can go to the AWS marketplace and with one click provision our storage and sell enterprise storage with one click, it is pretty fascinating compared to the nine months of one year cycle of storage boxes. It also helped us as a company, as I said, with the innovation rate, with the way that we see things, the way that we sell, the way that we're marketing, I think that today, startups not only need to have a really good product and innovation in the product, but we need to be innovative on marketing, we need to be innovative on how we sell. Sell is no longer, I sell to you and you buy from me, it's more of a partnership. And competition is also a partnership, so people need to be all the time thinking about, okay, how I need to work with you so it's mutual benefit for both of us. So we've talked about enterprises in terms of your business model, we talked about what Amazon was talking about what they've announced before. Talk to us about some of your customers outside the enterprise, maybe in the startup space, we know there's a big pool of low hanging fruit there on the Amazon side. Do you play in that space as well with AWS? Yeah, yeah, so basically we offer storage and block storage, file storage as a service and storage is a very horizontal type of field, startups need storage, enterprises need storage. So we do have customers that are small startup, just starting and we do have customers that are really big, 1450, customers that are using our storage as well. So again, the premise is that we provide a very highly configurable storage with performance, security and data protection features comparable to enterprise storage, right? But provision from a console in a minute and pay for what you use. And obviously for startups, it's good. I mean, the whole as a service for startups is really good. We as a company, ourself, we use the cloud for ourself, we started in the cloud from day one. We don't have IT department, you know, on premise. So that's a great story. We like Siddharah, but let's jump to it. How do the customers, what do the customers do with this flexibility? What do you see in the customer behavior that they can do now, your customers, that they just couldn't do before having this flexibility on the store? You know, how do they really take advantage of what you're offering? So a good example, we have a university that started with us. I think they started back in December, December, 2015, like six months ago, seven months ago. And we provision, this case is on premise and they actually start looking to do cloud as well. So we provisioned the first hardware that they did for a particular project. They said, oh, we need to connect VMware and this and that. And since then, every week or every two weeks, they provision more storage for different applications. Some are traditional applications like Exchange and VMware and things like that, that they still want to see the traditional storage, the Iskasi, Block, Fiber Channel, NFS, SIFS, this kind of thing. And some are new applications that are more of the object storage and connected to AWS and so on. So our vision is that we are providing storage for different kinds of application. We do really well the separation of workloads between customers and between, even the workloads of the same customer. So a customer can have a flash only, low latency, Fiber Channel block for the super high performance storage. And at the same time, on the same cloud can have another customer or the same customer, a workload that is more of a file oriented, the large capacity, low cost per gigabyte and so on. So what they like is the capability to go to the console and provision and have one minute later the storage ready to go rather than I need to call this vendor for NAS, I need to call this vendor for flash, I need to call this vendor for block. That's great. And two, kind of the traditional storage paradigm was you were always overextended, right? You always had to buy more than you needed because you had to get it in chunks and it took forever. So your efficiency was significantly less than you can do now kind of on demand. Yeah, the user experience, whether it's in the public cloud or private cloud is exactly the same. You go to the console, provision is ready to go. We manage the system for the customers, we monitor the system for the customer. When they reach a certain level of utilization, we call the customers, hey, we are going to ship you a couple of boxes for free. You don't need to do anything. All you need to do is to connect the boxes into the rack and we do all the remote DevOps and so on. And they are always storage ready to go for next time that you need provision storage. So what's next? What are you looking at? What's coming up down the road? What are you guys focused on? Yeah, so we do, first of all, as I said, we are trying to extend more and more workloads. Storage need to be configured specific for every need. And this is our expertise, right? As opposed to having a vinyl storage, or having a vanilla type of storage, only one, we can provision storage for low latency, blog, file, enterprise file, CIFS, NFS, object, fiber channel and so on. So we are looking to add more services, more storage services. We are looking to, we are developing capabilities to better do the hybrid cloud. Today we do very easily remote replication for disaster recovery and movement, but there are things that can be improved and the main idea is that customers, whether the storage is in the public cloud or it is on premise or it is in a different cloud, they will have a single console that can manage all the storage and easily move things back and forth. And are you going to butt heads with some of the Amazon products in doing that or are there some places like, I'm just picking one Glacier, where you don't want to play in that space and potentially stuff would be migrated. How do you kind of work with the Amazon offerings or you just compete head to head or how does that kind of work? Okay, in general the philosophy is that we offer storage. We try to get a higher level of capabilities than Amazon. So we understand that if somebody can do in Amazon with Amazon product, not likely to come to that. Right, right, you got to value that, right? Yeah, so we are playing the value add. And we do a lot of things that Amazon don't do, but again, this is storage. So at the end of the day, we do compete with some of their products. Some of the customer can do with Amazon, some others cannot do. Again, we provide higher level functionality. A good example is just the release the EFS finally. We do NAS as well and they do NAS, but ours for example is integrated with Active Directory. It has Snapshot, Geo, Replication, and things like you will find more of an enterprise NAS type of capability and that's done. So some people will use this, some people will use that. And I think Amazon is aware of that and it's good for Amazon because at the end of the day, the customer is happy and even if they use us, they still use the compute of Amazon, the networking and all the other 150 more products. So you're dancing that line of complimentary versus competition very well and really out of that, have a very symbiotic relationship, their innovation drives your innovation. Yes, and I think that Amazon is doing the same. So Amazon is well known for being a really good partner but competing with the partner, sometimes hiding from the partner. Right, right. So it is an interesting game I would say and we enjoy playing. All right, so I'll give you the last word. So Andy Jassy's a big fan of theCUBE, he's been on theCUBE, I think he was down when you were on it at ReInvent. If you were talking to Andy Jassy as a representative of the ecosystem, what are two things would you say? Andy, things are great, but could you please do? Mm. That's a good question. And so one of the things that we, and again with Amazon we have a special relationship because we do things a little bit different so they changed their direct connect in order to accomplish us. We are now in the Amazon marketplace as a special exception that they did for us and they are really good at us. So yeah, we would like more of the Amazon marketplace to be, you know, to have more marketing around, easy to find, if we could be the Amazon console will be great. Very good. Andy, please. Andy, you heard it. Andy, give Nelson some love, you know, get him up to the top of the select. It's kind of like an Apple store, right? Exactly. A thousand applications, how am I supposed to find my favorite one? All right Nelson, well thank you for stopping by and giving us the desired update and congratulations on all your success. Thank you very much. It was a pleasure to see you. Absolutely, I'm Jeff Frick. She's Lisa Martin. You're watching theCUBE and we're at AWS Summit. Santa Clara, we'll be back with our next guest after this short break. Thanks for watching. Thank you.


U.S. Senator warns Iran, if you escalate this war, we're coming for you. U.S. Senator Lindsey Graham gave a stark warning to Iran, telling the country to stay out of the war between Israel and Hamas, warning Iran that if Hezbollah, a Lebanese militant group, escalates the war, we're coming for you. If Hezbollah, which is a proxy of Iran, launches a massive attack on Israel, I would consider that a threat to the state of Israel existential in nature, Graham said on NBC. I will introduce a resolution in the United States Senate to allow military action by the United States in conjunction with Israel to knock Iran out of the oil business. Iran, if you escalate this war, we're coming for you. All Palestinians are not the same. If Hamas is destroyed, Israel is safer and the pathway to peace between the Palestinians and the world gets wider, he added. U.S. and Israeli officials have also said they are unsure if Iran was involved in the attack. But a spokesperson for the Israel Defense Forces told Politico they were 100% sure that the Iranians were not surprised by the attack. A spokesperson for the Israeli military also warned Hezbollah. I would highly recommend that Hezbollah watch very closely what is happening to Hamas and their organization in Gaza as we speak. Lieutenant Colonel Peter Lerner said on ABC's This Week. If they have, they should be very cautious of crossing that threshold because we are determined to defend the state of Israel.


Christiana says, I'm using Google Calendar and trying to get my Outlook Calendar to sync. It has been working, but it has been intermittent and now completely fails. I need to get this fixed, so please help, or I will have to go back to beloved Lotus Notes. Okay, somebody's adjusted. Lotus Notes. You're just like, here's his Lotus Notes. He's loved it. Oh, how I could rant about this, because this is something that happened to me today. It's actually, you know, it's a real problem for folks, because from a corporate standpoint, you have corporate policies and standards, and they say they don't want to pay Microsoft for their licensing, so they go with Google because it's cheaper, you know, and some of it's free. And then you're so used to using on your own desktop the Office applications and Microsoft stuff, or you came from another employer that only used Microsoft stuff and didn't touch Google because, you know, Google is, you know, their applications are less than, in my opinion, what Microsoft Office is. But the thing is, is that you need a place to have your calendars in a central location. That's the biggest deal, right? Because even mail, calendar, whatever, and getting those two to sync is a nightmare. It really is. You can share a calendar from Outlook and put it in as an ICS file inside of Google calendar through the website, but then it just stops working after a while, or you notice that you're not, you don't have the same appointments that you have between the two, and you actually have to shut both of them down and then wait for Google to, you know, if it does actually sync at some point. And it's really a pain. Now there's some third party things out there. One is a big script, a Google script that I put in that works pretty well, but you have to be pretty knowledgeable about how to do scripting in order to do it. And then somebody else came out with something called the Outlook-Google sync. And it was one of the MVPs, I think, that actually created it. And it's free. You can download it, but it's in beta. It's alpha and beta. And I tried it today, and it crashed on me, so I couldn't even use it. But this is, you know, not something new. And to get this right, I don't know what the answer is, because right now the only thing that's working for me is the script. We helped a couple of family and friend members, and it comes down, is it business or is it personal? Because if it's in the personal, it's like a personal space. Have they done it as a pop? Have they done it as an IMAP? Have they, you know, sometimes they've had to change it from one to the other, and then it was working fine and it didn't have any problems. I mean, that one was one on the personal side. How are they adding their calendar in? Are they doing it, you know, is it Outlook or is it mail? And sometimes they think they're doing Outlook on a Windows device and they're using mail, really. So what application do you actually have? What version application, you know, are you using Still Outlook 2013? 16. Are you using the latest? Because I've had ones that were using 2013. They were using a pop and Gmail. Have the new Outlook whether you wanted it or not? Yeah, that's it. So, you know, I kind of go, there's so many other questions that come into this because, you know, if it's on the personal side, there's so many things that could be going wrong. Yeah. And the silliest things will come up from that. It's like, if you look, one of the things for all of its faults, the old mail and calendar app on Windows 10 and Windows 11 did, was it, for those who use it, it gave you a unified inbox. You could have an inbox with all of your mail. The new Outlook doesn't do that. There is about, oh, I don't know. It was about 18 pages long. The thread on the answers form about, I'll never use this until they, it just takes it. There's so many things that are not available in the new Outlook, like search folders and quick parts. And I could go on and on. I'm hoping that they get it all. Send to Teams. Yeah. It's coming slowly. It's on road maps, but still not so fast enough. But that's true. I mean, there's so many different things. Going back to kind of the core question here too is that, you know, what version are you talking about of Outlook? You know, you can, because you look, there's plenty of info out there on exporting your Outlook calendar over sharing it with and syncing with it. If it's not syncing on a regular basis, maybe you have to do a manual update. It is, there's got to be like, Mike, you talked about using a script. There's things like there's other integrations. Is this than that? So again, can keep two calendars in sync that way. Every time an item is created one calendar, you have basically have two different bots out there that will then go and send, you know, create a similar item over on the other corresponding calendar. The other question is, there's more of a comment or question, but, you know, and, and I don't know how much this used to be the case that also both Google and Microsoft being fierce competitors would do things knowing it would break some of the Yeah, yeah, that's really happening anymore. But yeah, I mean, but I got to say, I mean, this is 2023. Right.  You know, like you just talked about both Heather and Christy. That doesn't make any sense to me. It also doesn't make any sense that things just can't talk to each other. I mean, there's no reason for that.  You got medical record systems that can talk to each other. You have airline reservation systems that can talk to each other. And it's just because it's something that needs to be done. But then you have these two companies that are just like, you know, to protect don't want to mess with each other and oh, we're going to make everybody's life, you know, crazy. It's just, I tell you, the two frontiers out there are task management and calendars. Well, it is because we get so many questions are in calendars. It's not funny. Crazy amount of questions. So guys, clean up. I believe it. Well, not only that, but I had an experience. We were talking about this in the call. I had an experience where I was coming from Evernote.  Well, if I created a tool called OneNote and I wanted to get customers that were using Evernote over to my product, would I not create some kind of import method to be able to bring those people over? But no, Microsoft has nothing, nothing. Evernote has got a OneNote importer. I know that. But why would why would they not do that? Because people would use their product then. I know, but. Just doesn't make sense to me. It just, it makes little sense that the size of that company. The product community can make money. The product community can make money. That's a little tiny $29 plug in, you know, I. I don't know. Yeah. That's a broader philosophical question about Microsoft, how they prioritize their, their product development. But I mean, I, I think the answer to a lot of questions and sometimes, especially as MVPs were so passionate and active in the community is that some of some of the things like, yeah, could they do it? But it wouldn't. Close more tickets or it wouldn't sell more net new licenses. Therefore, it's not a higher priority. I get it. Cause OneNote's free, right? Yeah. Okay. Yeah. Well, and I think, you know, a lot of efforts going into loop and all the integrations with the other applications on that too. So I think that there's, there's a lot of pieces that have to fall into place and then maybe, maybe we would see something on that. But I hope eventually you'd hope it would help the calendaring because that is a big issue. I mean, it's just, you know, it's a nightmare to, I remember when trying to just bring in Gmail into outlook. That was a process.  And it knows what to put in there for the right ports and all that other kind of stuff. No, it's a result because everybody's Gmail account is just their garbage account and they have their work account. That was Yahoo in AOL. Yeah. Let's not start on Yahoo. Oh my Lord, let's not start Yahoo.  Jesus. That's actually live.com. Ha ha. Ha ha. Ha ha. And then you get into the whole of lost things.


So, for the next hour or so, we're going to talk about a series of topics, immunotherapy, targeted therapy, phase one trials, a panel discussion, and then some additional topics toward the end of the day. We'll have you all out of here promptly by about 2.15 to 2.30. And what I'm going to talk to you about is immune-based therapies.  So I started today talking to you about the transition from the last decade of clinical research and available treatments for kidney cancer to what is really a pivotal time in our kidney cancer history. And as many people think about it, they think that it's something that just began, but in fact it's been decades in the making. So let me, there's four areas that I'd like to talk to you about in the next couple of minutes. The first is something called spontaneous regressions. The second is immune-based therapy with drugs like interleukin-2 and what that's taught us. The third is the role of vaccine therapy. And lastly, we're going to talk about a new class of agents that is not yet commercially available, but that is for kidney cancer, but is reaching the clinic hopefully in the very near future. And I can talk to you a little bit about the pluses and minuses of that. So let's start with spontaneous regressions. So it's been known for decades that kidney cancer is one of the few cancers that when you take out the primary cancer, where there's been spread to other areas, that sometimes in the absence of any systemic treatment, those other areas either decrease in size or disappear. That's what's called a spontaneous regression. It occurs very infrequently, but it does occur. All documented in the literature. So one would ask themselves, what's the mechanism for why that occurs? And the mechanism is thought to be that the primary tumor, the kidney cancer in the kidney, makes molecules that suppress the immune system's ability to manage its cancer. And I think even though that's kind of a 1950s phenomenon in our cancer literature, it has really great importance in 2015, 65 years ago. Because we now know that cancers control our immune response very differently than when we get vaccinated. So for example, many of you got a flu shot this year. It's pretty typical. Everybody, you know, you watch the TV and the TV says, get a flu shot. And you would ask yourselves, well, why do I have cancer and my immune system can't manage my cancer when I get a flu shot? And the flu shot can help me mount a response so that I don't suffer from the flu that comes out this year. And the reason for that is that the cancer is very, very smart. It's not that the flu shots aren't smart. And what it does is it produces an environment around the cells that prevent our immune system from seeing it, reaching it, touching it, and destroying it. And that's what's called immune suppression. And it used to be thought that immune suppression in kidney cancer and other cancers was a result that something happened that happened far away from the cancer cell itself. And the reality is that it's happening right next to the cancer cell, a place called the tumor microenvironment. So the tumor, we always used to think as well, there's these other cells that are inside, and then there's the cancer cell, and it's the cancer cells that drives the conversation. And we now know that it's not just the cancer cell, but all the other cells that are there. And what we're doing fast forward is, well, I'll tell you about how we're manipulating that tumor microenvironment when I talked to you about checkpoint inhibitors. So that was spontaneous regressions. The first hint that kidney cancer might be different. If you said to me, well, Dr. Figlin, that must happen in a lot of cancers. The answer is no, it doesn't. Spontaneous regressions don't happen in very many cancers. And kidney cancer is one of the few and infrequent diseases that it occurs in. So then let's go forward and talk about IL-2 and interferon. So IL-2 is a protein. Some of you may have heard about it. Some of you may have received it. Some of you may have benefited from it. And it is a drug approved in 1992 that took about six years to get approved. So mid to late 80s until 1992. And what IL-2 does is it basically hammers, and I use that word advisedly, it hammers your immune system. It stimulates your immune system in a way that nothing else does. Not vitamins, not certain kinds of green, leafy vegetables, not anything that the pharmacist or the TV tells you are immune stimulants. But it's a drug that basically hammers your immune system.  And in kidney cancer, when you think about kidney cancer now, what is that, eight and 15, 23 years later from its approval, if you asked an audience, whether it's this audience or any audience about who are the multiple decade survivors of kidney cancer, it's patients that received IL-2. So Nancy and I have patients that are 20 plus years free of metastatic cancer from IL-2. The problem with IL-2, unfortunately, is that it's very infrequently works, usually less than 10% of the time, and it requires multiple hospitalizations in the intensive care unit where you get very, very sick. And it's not really been adopted by most physicians around the country, because, one, they don't have the experience, two, the frequency of benefit is low, and that's independent of trying to identify the people that are most likely beneficiaries. So one of the questions that I've spent a significant part of my scientific life is to try and identify who most likely benefits, because boy, if we could identify the people that would benefit, then we could treat just those and not use that treatment for people unlikely to help. And we have an article that just was published that looks at that, but fast forward 23 years and we, although we have tried, we've not been very successful. So the gentleman in the second row asked about chromophobe. We know that it doesn't work in chromophobe. We know that there's certain subpopulations of patients where IL-2 can work, but even so, the success rate is usually less than one in 10. But what it did tell us was that the interaction between the immune system and kidney cancer remains a potential for curative therapy. And remember I used that word earlier. So fast forward to the kind of 2005 to 2012, we're starting to talk about vaccines. What are vaccines? Well, vaccines are no different than the flu shot that you take. The flu shot is an inactivated flu of certain strains that stimulate your immune system to protect you against the virus. We now have at least two large randomized clinical trials in kidney cancer using two different vaccine approaches. Vaccine one is an off-the-shelf vaccine that's combined with a drug that many of you may have received, Sutent, or a drug like Votrient, where the hope is that we stimulate the immune system against things on the surface of the cancer cell, which when combined with Sutent results in improved long-term control of the cancer, that trial has been completed. We're waiting for the results. Results probably won't be known for another 24 months. The second is a little bit different, and that's a trial where the vaccine is actually generated from the patient's own tumor. This is what's called a personalized autologous vaccine, meaning that it doesn't come off the shelf. It comes from you, and we take that tumor and we process it. We extract what are called the proteins on the surface of that cancer. We grow it in the laboratory. We put it on top of your immune system cells called your dendritic cells, and we give them back to you as a vaccine, much like a flu vaccine in combination with Sutent. That trial has now about 300-plus patients on it of the 450 that will be required. It's a trial taking place at 160 places around the world, and we'll hopefully have the results of that by 2016, about a year and a half from now. One can imagine that we are now trying to exploit your immune system on behalf of destroying your cancer. The last area, which is incredibly novel, is the realization, and this was actually first described in kidney cancer mid-2000s, so about 2004, by a group at the Mayo Clinic, Eugene Kwan. What they described was that there are these molecules on the surface of a kidney cancer cell which make the outcome for that patient less well than if the molecules were not on the surface of a kidney cancer cell. And then fast forward about eight years, travel from Rochester, Minnesota, to Baltimore, Maryland at Johns Hopkins, they realized that these molecules called checkpoint inhibitors are molecules that do the following. The cancer cell tells your immune system through something that it makes to block the immune reaction between your cancer and the cancer cell, between the immune system and the cancer cell. So imagine that this is the cancer cell and this is your immune system, there's something in between that despite a strong reaction can never see each other and interact. And that blocker was understood and as most of what happens in the world of oncology, industry gets involved at some point and we developed blockers to the blocker and you do that in the form of an antibody. So what you do is you say to the immune system, I'm going to give you this treatment and what's going to happen is the immune system that is being blocked by the signal between the cancer cell and the immune system is going to be blocked further by this drug that we're going to give you, a so-called checkpoint inhibitor blocker. Lo and behold, you clone it, you make it, you give it to people and there are now two diseases that, well, one and a half, let's say, where this drug has been beneficial, this class of drugs. It's approved in melanoma and it's soon to be approved in lung cancer. And what's amazing about this approach is that it's evident that diseases that are not thought to be immunologically reactive are now becoming responsive to immune manipulation, lung cancer, for example, where you wouldn't have expected that to occur. So we've participated in the kidney cancer trials, those trials have accrued, met all of their goals and we're waiting for those results and we would expect that kidney cancer will be one of the diseases where these checkpoint inhibitor blockers will be approved hopefully in 2015, possibly in the first half of 2016. Now, but we've learned a lot, going back to our IL2 conversation, that only about one and 10 benefit and the same is going to be true for the checkpoint blockers and that is that despite the fact that it's very exciting, it doesn't appear that everyone benefits from these drugs and we think that the benefit usually resides in about 20 to 30 percent of the patients. So again, much like the science that we did over the last couple of decades, it will be what is it about these people and what is it about this disease that allows these immunologic manipulations to work in some people and not in others. The other challenge is that when you turn on an immune system or you block the things that are blocking the interaction, you then are exposed to other immune reactions that might not be okay. You can develop diseases of the thyroid, of the adrenal gland, of the pituitary, of the gastrointestinal tract because when you turn on an immune system, you sometimes don't have complete control over the interaction between the immune system and the cancer cell or the immune system and other parts of our body. So while very exciting, also potentially very challenging with respect to how it's given, how it should be combined with other agents and who are the best people to receive it. So I'll circle back and talk to you about this later when we talk about some of the research that we and others are doing toward the end of today, but I think that my own bias is that the immune approach to kidney cancer, which was quiescent over the last decade, has reblossened and that reblossing of that effort is going to have a profound impact on the kinds of things that we can offer you and patients like you in the future. So I'll take a couple questions because we have a couple minutes and then we'll move on to some other topics, but we'll have a panel discussion later. Any questions? Perfectly clear. Dr. Mr. Kot, you must have a question. Use the microphone. Exactly. Yes. Yes, so the question that's being asked is there are five companies that are now internationally competing for this space. All of them with a little bit of a different approach. And the question is if one doesn't work, might the other one work? And we don't have any evidence that that's true yet. There's no data in the literature that would suggest that if A is ineffective that B can be effective, but we will see those evolve over time probably within this year, but currently there's no evidence that that's true. Following up on the questions about biomarkers from Dr. Lutheringer, are there real good tests to indicate which patients at this point are more likely to respond to some of these checkpoint inhibitors or ways to exclude patients? Right, so the easy answer to that question is there are no good tests to predict who will be a beneficiary and who will not. Those are tests that are being looked at and evaluated, but there is not a blood test, a tissue test, or some other kind of test that can predict how a person will do, although we look continuously.